Breaking News

MedPharm Completes FDA Inspection for Commercial Manufacture of Drug Products

MedPharm’s purpose-built facility in Durham accommodates research, development, analytical laboratories and robust quality assurance systems.

Author Image

By: Charlie Sternberg

Associate Editor

MedPharm’s topical drug product manufacturing facility in Durham has successfully completed a U.S. Food and Drug Administration (FDA) inspection for commercial manufacture of drug products. “I am pleased to mark this significant milestone, which reflects our organization’s unwavering commitment to quality and our continued focus on operational excellence,” said Bill Humphries, CEO of MedPharm. “For our valued clients—who rely on MedPharm for our proven innovation, technical expertise, and man...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters